Kazia Therapeutics Future Growth
Future criteria checks 3/6
Kazia Therapeutics is forecast to grow earnings and revenue by 49.6% and 47.7% per annum respectively. EPS is expected to grow by 59.7% per annum. Return on equity is forecast to be 25% in 3 years.
Key information
49.6%
Earnings growth rate
59.7%
EPS growth rate
Biotechs earnings growth | 16.1% |
Revenue growth rate | 47.7% |
Future return on equity | 25.0% |
Analyst coverage | Low |
Last updated | 10 Aug 2023 |
Recent future growth updates
Recent updates
We're Not Worried About Kazia Therapeutics' (ASX:KZA) Cash Burn
Jun 24We're Not Worried About Kazia Therapeutics' (ASX:KZA) Cash Burn
Feb 24We Take A Look At Why Kazia Therapeutics Limited's (ASX:KZA) CEO Compensation Is Well Earned
Nov 03We Think Kazia Therapeutics (ASX:KZA) Can Easily Afford To Drive Business Growth
Sep 23We Think Kazia Therapeutics (ASX:KZA) Can Afford To Drive Business Growth
May 04When Will Kazia Therapeutics Limited (ASX:KZA) Turn A Profit?
Mar 27Could The Kazia Therapeutics Limited (ASX:KZA) Ownership Structure Tell Us Something Useful?
Feb 28What Can We Learn About Kazia Therapeutics' (ASX:KZA) CEO Compensation?
Feb 01We Think Kazia Therapeutics (ASX:KZA) Can Afford To Drive Business Growth
Jan 06Bullish: Analysts Just Made An Incredible Upgrade To Their Kazia Therapeutics Limited (ASX:KZA) Forecasts
Dec 11Kazia Therapeutics Limited (ASX:KZA): When Will It Breakeven?
Nov 26Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2026 | 3 | -17 | N/A | N/A | 1 |
6/30/2025 | 11 | -6 | 7 | 7 | 2 |
6/30/2024 | 11 | -7 | 7 | 7 | 2 |
6/30/2023 | 0 | -20 | -15 | -15 | N/A |
3/31/2023 | 0 | -23 | -18 | -18 | N/A |
12/31/2022 | N/A | -25 | -20 | -20 | N/A |
9/30/2022 | 0 | -25 | -21 | -21 | N/A |
6/30/2022 | 0 | -25 | -23 | -23 | N/A |
3/31/2022 | 8 | -20 | -15 | -15 | N/A |
12/31/2021 | 15 | -15 | -8 | -8 | N/A |
9/30/2021 | 15 | -12 | -9 | -9 | N/A |
6/30/2021 | 15 | -8 | -9 | -9 | N/A |
3/31/2021 | 8 | -11 | -14 | -14 | N/A |
12/31/2020 | 0 | -13 | -18 | -18 | N/A |
9/30/2020 | 1 | -13 | -14 | -14 | N/A |
6/30/2020 | 1 | -12 | -9 | -9 | N/A |
3/31/2020 | 1 | -11 | -7 | -7 | N/A |
12/31/2019 | 1 | -10 | -5 | -5 | N/A |
9/30/2019 | 1 | -10 | -6 | -6 | N/A |
6/30/2019 | 1 | -10 | -7 | -7 | N/A |
3/31/2019 | 2 | -11 | -6 | -6 | N/A |
12/31/2018 | 2 | -12 | -5 | -5 | N/A |
9/30/2018 | 3 | -9 | -7 | -7 | N/A |
6/30/2018 | 3 | -6 | -9 | -9 | N/A |
3/31/2018 | 4 | -6 | -10 | -10 | N/A |
12/31/2017 | 6 | -6 | -12 | -12 | N/A |
9/30/2017 | 7 | -8 | -12 | -12 | N/A |
6/30/2017 | 9 | -11 | -11 | -11 | N/A |
3/31/2017 | 7 | -12 | N/A | -12 | N/A |
12/31/2016 | 5 | -12 | N/A | -12 | N/A |
9/30/2016 | 4 | -12 | N/A | -12 | N/A |
6/30/2016 | 3 | -12 | N/A | -12 | N/A |
3/31/2016 | 3 | -10 | N/A | -12 | N/A |
12/31/2015 | 3 | -9 | N/A | -12 | N/A |
9/30/2015 | 2 | -8 | N/A | -9 | N/A |
6/30/2015 | 2 | -7 | N/A | -6 | N/A |
3/31/2015 | 2 | -7 | N/A | -5 | N/A |
12/31/2014 | 2 | -7 | N/A | -5 | N/A |
9/30/2014 | 1 | -7 | N/A | -5 | N/A |
6/30/2014 | 0 | -7 | N/A | -6 | N/A |
3/31/2014 | 0 | -6 | N/A | -5 | N/A |
12/31/2013 | 1 | -5 | N/A | -3 | N/A |
9/30/2013 | 1 | -3 | N/A | -6 | N/A |
6/30/2013 | 1 | -2 | N/A | -9 | N/A |
3/31/2013 | 1 | -1 | N/A | -11 | N/A |
12/31/2012 | 1 | 1 | N/A | -13 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: KZA is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: KZA is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: KZA is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: KZA's revenue (47.7% per year) is forecast to grow faster than the Australian market (4% per year).
High Growth Revenue: KZA's revenue (47.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: KZA's Return on Equity is forecast to be high in 3 years time (25%)